Aspen Aerogels reported record quarterly revenues of $117.8 million, a 145% increase year-over-year, and a net income of $16.8 million, compared to a net loss in the same quarter last year. The company's adjusted EBITDA was $28.9 million, demonstrating significant operating leverage. Aspen has increased its 2024 revenue and profitability outlook for the second consecutive quarter.
Aspen Aerogels achieved record quarterly revenues of $117.8 million, marking a 145% increase year-over-year.
The company reported a net income of $16.8 million, a significant improvement from the net loss of $15.4 million in the second quarter of the previous year.
Adjusted EBITDA reached $28.9 million, showcasing the operating leverage of Aspen's business model.
Aspen Aerogels increased its 2024 revenue and profitability outlook for the second consecutive quarter, reflecting confidence in future performance.
Aspen Aerogels updated its 2024 full year outlook, expecting revenue growth between 59% and 63%. The company's outlook assumes depreciation and amortization of $30 million, stock-based compensation expense of $14 million, other (income) expense and income tax expense of $9 million, and diluted weighted average shares outstanding of 79.3 million for the full year.
Analyze how earnings announcements historically affect stock price performance